If you are suffering from menopausal symptoms read on…

Believe or not, doctor prescribed treatment options, such as hormone therapy, can lead to some undesirable side-effects, such as fatigue, mood-swings and in a few documented cases an increased cancer risk. In these instances, natural-based solutions may be a better way to help alleviate symptoms.

It goes without saying that following a balanced healthy diet (rich in fruit and vegetables), while avoiding alcohol and caffeine will help. Coupled with regular exercise, these may help alleviate pesky symptoms.

Additionally, and this one may seem really obvious – drink lots of water. Stay hydrated.

Doctor Prescribed Treatments and Natural Supplements in capsule form.

Diagram the demonstrates the cycle: decline in estrogen, less anadamide, less homestasis, more hot flashes compared balance that can be achieved when cannabinoids are taken.

Understanding Why Symptoms Occur

(Above) A reduction in Estrogen has a knock-on effect

What is the endocannabinoid system and does it help control hot flashes and night sweats?

Within our bodies, the human endocannabinoid system is responsible for numerous functions: from regulating our body temperature to mood/anxiety control and sleep patterns.

To add to this, recent research indicates that the endocannabinoid system also plays a significant role in helping regulate fertility and the reproductive system.

Inside our bodies, a naturally produced endocannbinoid – Anadamide* occurs at higher levels during ovulation. Essentially, higher levels of plasma containing Anadamide correlates to higher levels of estrogen.

A few studies have demonstrated that the body’s natural production of Anadamide may be directly linked with the hormone Estrogen. One study in particular was able to correlate an increase in cannabinoid receptors as well as plasma levels containing Anadamide, when Estrogen was administered.

The chemical structure for Anadamide AEA

Also known as N-arachidonoylethanolamine

*Anadamide is a naturally-occurring cannabinoid produced by the human body.

What does this tell us?

In reality, more research needs to be done. However, current data may suggest that when the levels of Estrogen go down, we need to find a way to increase the levels of endocannabinoids. That is to help prevent hot flashes and night sweats (amongst other things).

Data suggests that therapeutic solutions that contain cannabinoids, such as tetrahydrocannabinol (THC), may be successful in dealing with the vasomotor symptoms (e.g hot flashes, night sweats). As well as helping with other symptoms, such a good night’s sleep or regulating mood. Although, as ever, results vary and depend on each individual’s genetic make-up.

Because THC mimics the behavior of the endogenous cannabinoid Anadamide, it may offer Menopause suffers some welcome benefits. In any case CBDs/CBGs may also help regulate homeostatis, ensuring that vasomotor balance is restored.

Our goal is to share more scientific research on this topic as it becomes available.

Chemical Structure of CBD, CBG and THC


Cannabinoids that may mimic natural endocannabinoids and/or interact with Cannabinoid receptors in the human body.

Related Scientific Papers

Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause—global prevalence, physiology and implications. Nat Rev Endocrinol 2018;14:199–215. doi: 10.1038/nrendo.2017.180 [PubMed] [CrossRef] [Google Scholar]
McNamara M, Batur P, DeSapri KT. In the clinic. Perimenopause. Ann Intern Med 2015;162:ITC1–IT15. doi: 10.7326/AITC201502030 [PubMed] [CrossRef] [Google Scholar]
English M Stoykova B Slota C, et al.. Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS sleep disturbance and sleep-related impairment measures for assessment of VMS impact on sleep. J Patient Rep Outcomes 2021;5:37. doi: 10.1186/s41687-021-00289-y [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health Across the Nation. Obstet Gynecol Clin N Am 2011;38:489–501. doi: 10.1016/j.ogc.2011.05.006 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Gartoulla P, Bell RJ, Worsley R, Davis SR. Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife. Maturitas 2015;81:487–492. doi: 10.1016/j.maturitas.2015.06.004 [PubMed] [CrossRef] [Google Scholar]
Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes 2005;3:47. doi: 10.1186/1477-7525-3-47 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Hill DA, Crider M, Hill SR. Hormone therapy and other treatments for symptoms of menopause. Am Fam Physician 2016;94:884–889 [PubMed] [Google Scholar]
The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2018;25:1362–1387. doi: 10.1097/GME.0000000000001241 [PubMed] [CrossRef] [Google Scholar]
Karasu T, Marczylo TH, Maccarrone M, Konje JC. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum Reprod Update 2011;17:347–361. doi: 10.1093/humupd/dmq058 [PubMed] [CrossRef] [Google Scholar]
El-Talatini MR, Taylor AH, Elson JC, Brown L, Davidson AC, Konje JC. Localisation and function of the endocannabinoid system in the human ovary. PLoS One 2009;4:e4579. doi: 10.1371/journal.pone.0004579 [PMC free article] [PubMed] [CrossRef] [Google Scholar]